This year, consumer stocks have been hammered as inflation lingers at 40-year highs and interest rates rise. The Dow Jones U.S. Consumer Goods Index is down 20% this year as consumers pull back on their spending. However, some consumer-focused companies have performed worse than others. Much worse.  Whether it is due to poor management, failure to adapt
0 Comments
Ryan McQueeney discusses the end of the semiconductor super cycle and compares Texas Instruments and Broadcom, two chip stocks that dividend investors might have on their radars right now. Texas Instruments: https://www.zacks.com/stock/quote/TXN?cid=CS-YOUTUBE-FT-VID Broadcom: https://www.zacks.com/stock/quote/AVGO?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: stocktwits.com/ZacksResearch Follow us on Twitter: twitter.com/ZacksResearch Like us on Facebook: www.facebook.com/ZacksInvestmentResearch
0 Comments
Wall Street has not been kind to most financial stocks so far in 2022. Despite the potential for bank earnings to increase due to rising interest rates, worries over a global recession have weighed on many bank shares. Today we will examine three undervalued bank stocks that provide investors with good buying opportunities. The banking
0 Comments
Lauren Taylor Wolfe, center, Roy Swan, left, and Shundrawn Thomas at CNBC’s Delivering Alpha, Sept. 8, 2022. Scott Mlyn | CNBC ESG and sustainable investing generally have come under fire recently, with critics pointing to a lack of transparency and differing definitions sparking confusion around what investors are actually buying. Adding to the confusion is
0 Comments
Bitcoin vs. Ethereum: An Overview  Ether (ETH), the cryptocurrency of the Ethereum network, is the second most popular digital token after bitcoin (BTC). As the second-largest cryptocurrency by market capitalization (market cap), comparisons between Ether and bitcoin are only natural. Ether and bitcoin are similar in many ways: Each is a digital currency traded via
0 Comments
[Editor’s note: “Muscle Through a Recession With Growth Stocks” was previously published in June 2022. It has since been updated to include the most relevant information available.] Lately, the stock market has been getting crushed. It’s clear that we’re in the middle of a bear market. And it seems likely that the U.S. will see
0 Comments
Cryptocurrencies have come a long way from their relatively obscure origins. While the mainstream financial world once disdained digital currencies as tools for criminals and speculators, the industry has made significant progress in establishing itself as a legitimate and (potentially) world-changing space. Bitcoin (BTC) and Ethereum (ETH) have seen massive growth in price and users, but there
0 Comments
With precious metals prices continuing to move inversely to interest rates, some investors would say that the best precious metals stocks to own right now are none of them. If you view precious metals strictly through the lens of gold and silver, I can’t blame you. As inflation soared, gold and silver did not hold
0 Comments
When choosing an online broker, day traders place a premium on speed, reliability, and low cost. Features designed to appeal to long-term, infrequent traders are unnecessary for day traders, who generally start a trading day with no positions in their portfolios, make numerous transactions, and end the day having closed all of those trades. Our top
0 Comments
With so many different types of online brokers available to investors, it can be tough to choose one that works best for you. That’s why we put these U.S.-based online brokers through a comprehensive review process that included hands-on research to determine the best in the industry. We publish unbiased product reviews; our opinions are
0 Comments
Novavax (NASDAQ:NVAX) stock hasn’t had a great 2022, down 86% since the beginning of the year. The company focuses on products to treat infectious diseases but is definitely best known for its Covid-19 vaccine NVX-CoV2373, also known as Nuvaxovid. There are plenty of other competing vaccines in this category, and Novavax’s shots haven’t been strong sellers
0 Comments